# Study of EGFRBi Armed Fresh PBMC in Metastatic or Unresectable Pancreatic Cancer

Source: https://onco.cc/trials/nct06479239/  
OnCo record `nct06479239` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1/2 trial in pancreatic cancer, run by University of Virginia, now recruiting.

## Summary

Study of EGFRBi Armed Fresh PBMC in Metastatic or Unresectable Pancreatic Cancer is a phase 1/2, interventional study registered as NCT06479239 by University of Virginia, with a registry enrolment figure of 23 participants, started 2024-11-06 and due to reach its primary completion in 2027-12. Interventions recorded: EGFR FPBMC. Conditions listed: Pancreas Cancer; Pancreatic Cancer. Primary outcome: Dose limiting toxicities (DLTs) during the dose escalation phase (during the first 8 infusions only). Pancreatic eligibility wording from the registry: "Histologically confirmed locally advanced pancreatic cancer (LAPC)/unresectable pancreatic cancer (UPC) or metastatic pancreatic cancer (MPC) not eligible for curative intent therapy". Sites: United States. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Also known as: Panc 002
- Tags: ctgov-ingest; pancreatic-deep-dive
- Registry id: NCT06479239
- Phase: 1/2
- Setting: Phase I/II Study of Anti-CD3 x Anti-EGFR Bispecific Antibody (EGFRBi) Armed Fresh Peripheral Blood Mononuclear Cells (EGFR FPBMC) in Metastatic or Unresectable Pancreatic Cancer
- Sponsor: University of Virginia
- Enrolled: 23

## Sources

- ClinicalTrials.gov NCT06479239: https://clinicaltrials.gov/study/NCT06479239

## Connected records

- cancers: [Locally advanced unresectable pancreatic ductal adenocarcinoma](https://onco.cc/cancers/locally-advanced-pdac/), [Metastatic pancreatic ductal adenocarcinoma](https://onco.cc/cancers/metastatic-pdac/)
- terms: [Pancreatic cancer trials open today (registry snapshot and UK sites)](https://onco.cc/terms/pancreatic-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct06479239.json